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The fungal component of the intestinal microbiota of eight healthy subjects was studied
over 12 months using metagenome survey and culture-based approaches. Aspergillus,
Candida, Debaryomyces, Malassezia, Penicillium, Pichia, and Saccharomyces were the
most recurrent and/or dominant fungal genera, according to metagenomic analysis. The
biodiversity of fungal communities was lower and characterized by greater unevenness,
when compared to bacterial microbiome. The dissimilarities both among subjects
and over the time within the same subject suggested that most of the fungi passed
through the gastro-intestinal tract (GIT) without becoming stable colonizers. Certain
genera, such as Aspergillus and Penicillium, were isolated in a minority of cases,
although they recurred abundantly and frequently in the metagenomics survey, likely
being environmental or food-borne fungi that do not inhabit the GIT. Candida genus
was recurrently detected. Candida albicans isolates dominated among the cultivable
mycobiota and longitudinally persisted, likely as commensals inhabiting the intestine
or regularly reaching it from Candida-colonized districts, such as the oral cavity.
Other putative colonizers belonged to Candida zeylanoides, Geotrichum candidum,
and Rhodotorula mucilaginosa, with persisting biotypes being identified. Phenotyping
of fungal isolates indicated that C. albicans adhered to human epithelial cells more
efficiently and produced greater amounts of biofilm in vitro than non-albicans Candida
(NAC) and non-Candida fungi (NCF). The C. albicans isolates also induced the highest
release of HBD-2 by human epithelial cells, further differing from NAC and NCF. Nine
representative isolates were administered to mice to evaluate the ability to colonize the
intestine. Only two out of three C. albicans strains persisted in stools of animals 2 weeks
after the end of the oral administration, whereas NAC and NCF did not. These results
confirm the allochthonous nature of most the intestinal fungi, while C. albicans appears
to be commonly involved in stable colonization. A combination of specific genetic
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features in the microbe and in the host likely allow colonization from fungi normally
present solely as passengers. It remains to be established if other species identified
as potential colonizers, in addition to Candida, are true inhabitants of the GIT or rather
reach the intestine spreading from other body districts.
Keywords: gut microbiota, fungi, colonization, metagenomics, Candida
INTRODUCTION
The complex microbial community hosted in the gastrointestinal
tract (GIT) of humans and animals is composed of bacteria,
archaea, fungi, protozoa, and viruses (Qin et al., 2010; Huseyin
et al., 2017). The complexity of the GI bacterial population,
accounting up to 1012 microorganisms per gram of content, has
been widely investigated, while abundance, role, and diversity of
fungi in the human gut are still understudied (Huseyin et al.,
2017). Cultivable fungi in feces range between 102 and 106 cfu/g
(Simon and Gorbach, 1984), representing a minor component of
gut microbiota, and their genes cover less than 0.1% of the whole
microbial metagenome (Qin et al., 2010). Although several fungal
species are harbored in the normal GIT their potential role in host
health status have been only partially investigated (Seed, 2014;
Suhr and Hallen-Adams, 2015; Strati et al., 2016; Nash et al., 2017;
Auchtung et al., 2018; Borges et al., 2018).
Most studies on the human mycobiome have been focused
on opportunistic pathogens, such as Candida species, and in
particular Candida albicans (Mayer et al., 2013; Merseguel
et al., 2015; Cavalieri et al., 2018). This species colonizes
oropharynx, genital, and gastrointestinal mucosa of 30–70% of
healthy individuals, and colonization can evolve into infection
under certain circumstances, such as decay of host immune
defense or structural impairment of muco-cutaneous barriers
(Brandt and Lockhart, 2012). Disruption of mucosal barriers
and host immune defenses impairment may lead to endogenous
candidiasis arising from commensal strains (Yan et al., 2013).
Indeed, C. albicans is the most virulent species of the genus
Candida, due to several virulence factors and fitness attributes
that contribute to the pathogenic potential (Cavalieri et al., 2018).
The first step in the infection onset is the interaction between
Candida and host cells (Moyes et al., 2015). C. albicans, as
well as other Candida spp., expresses several adhesins, which
bind to extracellular proteins of epithelial cells. Adhesion of
fungi to the mucosal cell membrane may stimulate biofilm
formation, that increases the resistance to host immune
defenses and antifungal drugs. As many opportunistic pathogens,
C. albicans takes advantage from biofilm formation to escape
host immune defenses and antifungal therapy as well (Tsui
et al., 2016). Other Candida species, such as C. dubliniensis,
C. glabrata, C. guilliermondii, C. kefyr, C. krusei, C. tropicalis,
and C. parapsilosis can reside as commensal in diverse niches of
the human body and may be responsible of biofilm-associated
severe infections (Muadcheingka and Tantivitayakul, 2015).
Currently, the significant increase of infections caused by other
Candida spp. is matter of clinical concern, because of their
resistance to conventional antifungal agents (Merseguel et al.,
2015; Wu et al., 2017).
Nowadays, high throughput next generation sequencing
(NGS) has become a common technology for microbiome
studies and has overtaken traditional microbiological methods
for the identification of members of the microbial communities.
The knowledge on the bacterial component of the gut microbiota
has received a major impulse from 16S rRNA gene profiling.
Likewise, NGS targeting the Internal Transcribed Spacers
(ITS) within eukaryotic rRNA genes allows to characterize
the intestinal fungal population (Tang et al., 2015). Studies
investigating the composition of gut mycobiota identified
tens of fungal operational taxonomic units (OTUs), most
of which ascribed to Aspergillus, Candida, Cladosporium,
Clavispora, Cyberlindnera, Debaryomyces, Galactomyces,
Malassezia, Penicillium, Pichia, Rhodotorula, and Saccharomyces
(Hoffmann et al., 2013; Seed, 2014; Suhr and Hallen-Adams,
2015; Strati et al., 2016; Suhr et al., 2016; Nash et al., 2017;
Auchtung et al., 2018; Borges et al., 2018). Recently, a
strain specific analysis using whole genome sequencing of
single isolates was applied to study strain specific features
associated with the ability of Saccharomyces cerevisiae to
colonize the human gut, showing that strains from different
origin differ in the ability to adapt to the gut environment
(Ramazzotti et al., 2019).
Several factors affect the description of the mycobiota by
culture-independent sequencing, including non-standardized
methods of DNA preparation, the target of primers for
amplification, the consistency of taxonomic information in
reference databases, and the characteristics of the cohort (e.g.,
geographical location, diet, and climate) (Nash et al., 2017). In
particular, the selection of the best markers for profiling fungi
is debated, since ITS1 has been regarded as the best target for
profiling fungi, while the most recent studies indicate ITS2 as
more accurate (Wang et al., 2015; Yang et al., 2018). However, the
clustering and taxonomic capacities did not differ between ITS1
and ITS2, that generate similar patterns of community structure
(Yang et al., 2018).
The ecological and functional role of intestinal fungi, the
source (allochthones or autochtones), the interaction with the
host, and the capability to permanently colonize or to transit
through the GIT are topics that still deserve deep investigation
(Huseyin et al., 2017). The aim of the present study was
to investigate the presence and persistence of fungi in the
feces of eight healthy subjects using a combination of culture-
based approaches and metagenomics. The fungal isolates were
phenotypically characterized, assessing their ability to colonize
the murine GIT, adhere to human Caco-2 cells and induce the
release of human β-defensin 2 (HBD2), and to form biofilm
in vitro. In particular, the behavior of C. albicans, non-albicans
Candida (NAC), and non-Candida fungi (NCF) was compared.
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MATERIALS AND METHODS
ITS and 16S Amplicon Libraries,
Sequencing, and Analysis
DNA was extracted from feces using the FastDNA SPIN Kit
for Feces (MP-Biomedicals, United States). DNA quality was
checked on 1% agarose gel TAE 1X and quantified with a
NanoDrop spectrophotometer. Fungal ITS1 rDNA region was
amplified with a fusion primer set, consisting of 18SF and
5.8S1R primers (5′-GTAAAAGTCGTAACAAGGTTTC-3′
and 5′-GTTCAAAGAYTCGATGATTCAC-3′, Findley et al.,
2013) coupled with adaptors, key sequence and barcode,
according to 454 Sequencing System Guidelines for Amplicon
Experimental Design (Roche, Switzerland). Bacterial V1-
V3 hypervariable regions of the 16S rRNA gene were
generated with universal 27-Forward and 533-Reverse
primers (5′-AGAGTTTGATCMTGGCTCAG-3′ and 5′-
TTACCGCGGCTGCTGGCAC-3′, Barelli et al., 2015) coupled
with adaptors, key sequence and barcode (Roche, Switzerland).
ITS1 and V1-V3 regions were amplified according to Strati
et al. (2016) and Barelli et al. (2015), respectively. The PCR
products were electrophoresed, cleaned using the AMPure XP
beads kit (Beckman Coulter, United States), and quantified via
quantitative PCR using 454 Kapa Library Quantification Kit
(KAPA Biosystems, United States).
Equimolar amounts of purified amplicons were pooled
into ITS1 and 16S amplicon libraries, that were subjected to
pyrosequencing on the Roche GS FLX+ system using the
XL+ chemistry (Roche, Switzerland). Pyrosequencing reads were
processed using the MICCA pipeline for trimming and quality
filtering (Albanese et al., 2015). Quality filtered sequences were
processed with Qiime 2 pipeline (Bolyen et al., 2018) for closed-
reference OTU picking, taxonomy assignation, and diversity
metrics computation. For the fungal microbiota, the OTU
picking and taxonomy assignation were carried out utilizing
UNITE ver. 7.2 Dynamic Classifier1 as reference database with the
similarity threshold set at 0.97. For the bacterial microbiota, the
closed-reference OTU picking and taxonomy assignation were
carried out utilizing as reference SILVA SSU database release 1322
with the similarity threshold set at 0.97.
ITS1 and 16S rRNA gene sequences have been submitted to
NCBI repository with the BioProject ID: PRJNA545913.
Culture-Dependent Enumeration of Fecal
Yeast-Like Fungi
Fresh feces were collected from 8 healthy adult volunteers
(hereinafter referred to as V1–V8), 4 males and 4 females
aged 25–55, enrolled among the employees of the University
of Modena and Reggio Emilia and their relatives. The subjects
were not in relationship with the researchers, followed a
western omnivore diet, and had not been treated with prebiotics
and/or probiotics for 1 month and antibiotics for at least
3 months before being enrolled and throughout the study.
1https://unite.ut.ee/repository.php
2https://www.arb-silva.de/download/arb-files/
Written informed consent was obtained from all the enrolled
subjects, in accordance with the protocol approved by the local
research ethics committee (reference number 225-15, Comitato
Etico Provinciale, Azienda Policlinico di Modena, Italy).
Feces were collected and analyzed at the beginning
of the study (sample I), 3 (sample II), and 12 months
(sample III) later. Stool samples were collected in sterile
containers and forwarded to the laboratory within 3 h. The
fecal samples were serially diluted and 100 µL dispersed
onto Potates Dextrose Agar (PDA, BD Difco, Franklin
Lakes, NJ, United States) supplemented with 100 mg/L
chloramphenicol and 100 mg/L ampicillin. The plates were
aerobically incubated at 30◦C for 72 h, then fungal colonies were
counted and isolated.
RAPD-PCR Analysis of Fungal Isolates
and Taxonomic Attribution
For each fecal sample, 48 colonies from PDA plates were
subjected to RAPD-PCR clustering. Genomic DNA was
extracted and subjected to RAPD-PCR amplification according
to Raimondi et al. (2017). The reaction was performed in
15 µL of a mixture consisting of Dream Taq Buffer (Thermo
Fisher Scientific, Waltham, MA), 0.5 µM of M13-RAPD
primer (5′-GAGGGTGGCGGTTCT-3′), 100 µM of each
dNTP, 0.75 U Taq polymerase (DreamTaq, Thermo Fisher
Scientific), and 50 ng of gDNA from the isolates. The
thermocycle was the following: 94◦C for 4 min; 45 cycles
of 94◦C for 1 min, 34◦C for 1 min, and 72◦C for 2 min;
72◦C for 7 min. The PCR products were electrophoresed
for 4 h at 160 V in a 25 × 25 cm 2% (w/v) agarose gel in
TAE buffer. RAPD-PCR fingerprints were digitally captured,
then analyzed with Gene Directory 2.0 software (Syngene,
United Kingdom), which calculated similarities and derived
a dendrogram with an unweighted pair group method with
arithmetic means (UPGMA).
To attribute each biotype to a species, the ITS1 and ITS2
spacer regions were amplified, sequenced, and compared
with GenBank database. Amplification was performed with
ITS1 (5′-TCCGTAGGTGAACCTGCGG-3′) and ITS4 (5′-
TCCTCCGCTTATTGATATGC-3′) primers within 150 µL of
PCR Master Mix (Thermo Fisher Scientific), containing 0.2 µM
of each primer, and 50 ng of gDNA. The thermocycle was the
following: 95◦C for 5 min; 30 cycles of 95◦C for 1 min, 60◦C for
1 min, and 72◦C for 1 min; and 72◦C for 7 min.
Strain Typing of C. albicans
For microsatellite length polymorphism (MLP) typing,
the loci CAI and CAIV were amplified by PCR with 5′
fluorescently labeled forward primer (6-carboxyfluorescein)
according to Sampaio et al. (2005). The PCR products
were injected in an ABI 370 genetic analyzer (Applied
Biosystems, Foster City, CA, United States) and the
fragment sizes were determined using the GeneScan 3.7
software. For single-strand conformation polymorphism
(SSCP) electrophoresis analysis, approximately 100 ng of
unlabeled PCR products were loaded on an acrylamide
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gel and separated with a DCode Universal Mutation
Detection System (Bio-Rad, Hercules, CA, United States).
Electrophoresis and silver staining were performed
according to Li and Bai (2007).
Biofilm Formation Assay
Candida isolates were grown overnight in SDA plates at 37◦C.
Yeast cells were washed with PBS and standardized to 1 × 105
or 1 × 106 yeast cells/mL in RPMI-1640 medium (Gibco,
Grand Island, NY, United States) supplemented with 10%
heat-inactivated Fetal Bovine Serum (hiFBS; Defined Hyclone,
Logan, Utah, United States), 2 mM L-glutamine, and 50 mg/mL
gentamycin, hereafter referred to as cRPMI. The yeast cell
suspension was placed (0.1 mL/well) in a 96-well polystyrene
microplate and incubated at 37◦C for 24 and 48 h (Orsi et al.,
2014). After incubation, the biofilm was quantified by the crystal
violet (CV) assay. The cells were washed 3 times with PBS
at room temperature, fixed with methanol, stained with 1%
CV for 15 min, washed three times with distilled water, and
treated with 33% acetic acid for 10 min. The color development,
read at 540 nm (OD540), was proportional to biofilm. The
consensus threshold for biofilm formation was established at
OD540 = 1.5.
Human Epithelial Cells
The human epithelial colorectal adenocarcinoma cell line Caco-
2 was grown in 75-cm2 tissue-culture flasks (Nalge Nunc
International, Naperville, IL, United States). When reaching 80–
90% confluence, the cells were split 1:3 by standard methods. The
cells were cultured at 37◦C under 5% CO2 in Dulbecco’s Modified
Eagle Medium (EuroClone, Milan, Italy) supplemented with 10%
hiFBS, 2 mM L-glutamine, and 50 mg/mL gentamycin, hereafter
referred to as cDMEM.
Adhesion Assay
Caco-2 cells (6.5 × 105/mL, 200 µL/well) were seeded in
Lab-Tek II chamber slides, grown to confluence for 24 h
at 37◦C, then supplemented with a suspension of yeasts
(2.6 × 106/mL, 200 µL/well) in cRPMI at E:T ratio 1:2.
The cells were incubated for 1.5 or 3 h at 37◦C under 5%
CO2. Fifteen minutes before the end of incubation, 40 µL/well
of 1% Uvitex 2B (Polysciences Europe GmbH, Germany)
were added. The wells were washed three times with PBS to
remove the unbound yeast cells. The remaining yeasts were
fixed for 30 min with PBS-buffered 4% paraformaldehyde.
The Caco-2 cells were washed twice with PBS and then
treated with PLGAR (Thermo Fisher Scientific, Waltham, MA,
United States). The blue fluorescence of adhered yeasts was
visualized by epifluorescence microscopy Nikon Eclipse 90i
imaging system, equipped with Nomarski DIC optics (Nikon
Instruments Inc., Melville, NY, United States). Samples were
photographed with a DS-2Mv Nikon digital camera. The
percentage of adhesion was defined as the ratio between Caco-
2 cells with at least one adhering fungal cell and the total
number of Caco-2 cells observed. At least 200 epithelial cells per
sample were examined.
Secretory Activity of Human Epithelial
Cell Line Caco-2
Caco-2 cells suspended at 8.0× 105/mL in cDMEM, were seeded
(200 µL/well) in 24 well-plates and allowed to reach confluence
for 24 h at 37◦C. Yeast cells (1.6 × 108/mL, 1 mL/well, E:T
ratio 1: 100), 500 µg/mL β-D-glucan, or 10 µg/mL LPS were
added, and the plates were incubated for additional 24 h. The
supernatants were collected and the level of HBD-2 was assessed
by the enzymatic immunoassay β-2-Defensin Human (Phoenix
Pharmaceuticals, Karlsruhe, Germany).
Animal Trial
Nine intestinal yeast strains (C. albicans 02-10, C. albicans 04-
10, C. albicans 08-06, C. parapsilosis 01-18, Candida pararugosa
04-14, Candida zeylanoides 01-03, Geotrichum candidum 02-
01, S. cerevisiae 03-01, and Rhodotorula mucilaginosa 04-01)
were grown for 24 h in 200 mL of Potato Dextrose Broth
(BD Difco). The biomass was harvested by centrifugation,
suspended in PBS containing 15% v/v glycerol to obtain
single-dose aliquots of 107 cells in 150 µL and stored at
−80◦C. Aliquots were thawed one by one and utilized in the
animal trial. Yeast viability was confirmed by enumeration
onto PDA plates.
Six-weeks-old CD1 male mice were purchased from Envigo
Laboratories (Oderzo, Italy) and housed in groups of 2
per individually ventilated cage, in a temperature-controlled
environment (22 ± 2◦C) under a 12-h light-dark cycle. Chow
food and water were provided ad libitum. Mice were allowed
to acclimate to the laboratory for 1 week before entering
experimentation. Nine groups of 10 mice were established,
each group being assigned a yeast strain. The mice received
for 14 days a daily dose of yeast biomass via gastric gavage.
Controls were fed with 150 µL of PBS containing 15% v/v
glycerol. At the end of the treatment and after 2, 4, and
8 weeks of washout, fecal pellets were collected from each
mouse and immediately stored at -80◦C in pre-weighted tubes
containing 50% glycerol. Yeasts were counted onto PDA plates
supplemented with 100 mg/L chloramphenicol and 100 mg/L
ampicillin. Isolates were subjected to RAPD-PCR profiling, in
order to check the identity with the supplemented strain. This
study was carried out in compliance with the appropriate
laws and institutional guidelines (DL n. 116/92 art. 5). The
protocol was approved by the Animal Care and Use Ethics
Committee of the University of Padua, in compliance with
the national and European guidelines for handling and use of
experimental animals.
Statistics
In biofilm formation, adherence, and HBD-2 assays, the data
are presented as means ± SD of at least three independent
experiments. Means for C. albicans, NAC, and NCF groups
were compared with one-way ANOVA followed by Bonferroni’s
post hoc test and were considered significantly different for
P < 0.05. In the colonization assay, the viable counts at 2, 4,
and 8 weeks were compared to that at 0 weeks using Wilcoxon
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FIGURE 1 | Stacked bar-plot representation of the relative abundances of the main fungal taxa in the intestinal mycobiota, based on metagenomic ITS1 sequences.
Only the taxa with a taxonomic attribution at the level of phylum (A), family (B), and genus (C) and appearing at least once with abundance higher than 1% are
reported, all the others being grouped as “other and unclassified.”
signed-rank test T and were considered significantly different
for P < 0.05.
RESULTS
Fungal Communities Based on
Metagenomic ITS1 Sequencing
Fecal samples of eight healthy adults were collected at three
time points across a period of 1 year, i.e., 0, 3, and 12 months,
hereinafter referred to as samples I, II, and III, respectively, and
subjected to the profiling fungal and bacterial communities using
metagenomic ITS1 and 16S sequencing, respectively. Only 13 out
of 24 samples provided a valuable number of fungal reads, that
resulted in a total of 140,225 quality-trimmed ITS1 sequences (on
average 10,787 reads per sample) and 103 OTUs net of singletons
(on average 28.2 OTUs per sample, ranging from 11 to 40)
(Figure 1 and Supplementary Datasheet S1). The unsuccessful
sequencing was attributed to the too low concentration of fungal
DNA, likely due to high concentrations of non-target DNA and
to contaminants that may have been co-extracted with DNA. The
16S sequencing of the whole set of samples yielded 231,082 reads,
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FIGURE 2 | UPGMA cladograms of fungal (A) and bacterial (B) communities, constructed using the corresponding Jaccard distance matrices.
attributed to 343 OTUs net of singletons (on average 130 OTUs
per sample ranging between 81 and 178) (Supplementary Figure
S1 and Supplementary Datasheet S2).
The alpha diversity indices (Chao1, Shannon, and Pielou),
all lower for fungi compared to bacteria, indicated that
fungal communities presented lower richness and evenness
than the bacterial ones (Supplementary Figure S2). Fungal
communities were also more dissimilar/distant from each
other, while the bacterial ones presented evident subject-based
groups with the Jaccard beta diversity metric (Figure 2).
PERMANOVA analysis of beta diversity highlighted significant
differences among bacterial communities from different
subjects (P < 0.01), with the distance between the subjects
being generally greater than that within each subject. With
regards to the fungal community, no significant difference
among subjects was observed (P > 0.05), resulting from
great distances both among the subjects and in the same
subject over the time.
The fungal OTUs were ascribed to Ascomycota (62),
Basidiomycota (34), and Mucorimycota (5). Ascomycota and
Basidiomycota were ubiquitously present across the samples,
with the former, always being the most abundant, ranging from
47.8 to 99.5% and the latter from 0.5 to 13.9% (Figure 1).
Mucoromycota were generally negligible (not detected or <2%)
with the exception of the samples V2III and V3III (36.9 and
32.6%, respectively).
Within Ascomycota, the family Aspergillaceae was the most
frequent and on average the most abundant. The genus
Aspergillus was the most widespread and copious, accounting for
up to 72.5% (mean = 25.7%), while Penicillium was less than 1% in
most cases, albeit it dominated in sample V3II (62.6%). A number
of Aspergillus and Penicillium species occurred sporadically and
were negligible in terms of abundance, with the exception of
Aspergillus niger that was highly recurrent (11/13), although
being always less than 1%.
Other families of Ascomycota that reached remarkably
high amounts in few samples were Debaryomycetaceae
(mostly Debaryomyces), Dipodascaceae (unidentified genus),
Saccharomycetaceae (mostly Saccharomyces and Torulaspora),
Pichiaceae (Pichia), and the Saccharomycetales incertae sedis
encompassing the genus Candida. Debaryomyces udenii and
S. cerevisiae were the most frequent and abundant species.
D. udenii was identified in 11 out of 13 samples, with relative
amounts up to 89.5% (19.9% on average), while S. cerevisiae
was detected in 12 of 13 samples, with relative amounts up to
48.9% (13.9% on average). High levels of Pichia terricola and
Torulaspora delbrueckii characterized the samples V4III and
V8III, respectively. The genus Candida occasionally occurred
at remarkably high level, with only a few detected species (e.g.,
C. ethanolica, C. inconspicua, C. parapsilosis, C. tropicalis, and
C. zeylanoides), that never accounted for more than 0.5%.
C. albicans was never identified.
Basidiomycota mostly belonged to unclassified members of
Tremellomycetes (up to 9.7%) and to family Malasseziaceae
(genus Malassezia). Malassezia restricta was common (12/13),
reaching up to 3.8% of abundance. Mucor encompassed
most of the OTUs of Mucoromycota. Mucor piriformis
and Mucor circinelloides were recurrent (8/13 and 7/13,
respectively), reaching the remarkably high level of approx. 32%
in some samples.
In order to establish whether a relationship could occur
between bacterial and fungal genera, Spearman rank correlations
between the genera were calculated on the basis of 16S and
ITS1 metagenome analysis (data not shown). No significant
correlations between bacterial and fungal genera were found,
excluding the correlations resulting from bacterial and fungal
genera occurring only in a sample.
Enumeration, Isolation, and Taxonomic
Identification of Cultivable Fungi
In parallel to NGS profiling, the fresh fecal samples were spread
onto selective plates in order to determine the viable counts
of fungi. In five samples, the fungal load was below the limit
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of detection (<102 cfu/g), while it ranged from 1.4 × 102 to
4.5 × 105 cfu/g in the others (Table 1). A wide quantitative
variability was detected over the time within a same subject, with
a minority of cases presenting comparable fungal loads (P> 0.05)
between different time points.
Forty-eight colonies from each sample were randomly
selected and clustered into a total of 27 biotypes based
on their RAPD-PCR profile, referred to 11 genera and 17
species (Table 2). Some RAPD-PCR profiles of C. albicans,
C. parapsilosis, C. pararugosa, R. mucilaginosa, and I. terricola
were similar across different hosts, indicating that this
technique was unsuitable for typing such isolates at the
strain level. SSCP and MLP fingerprinting differentiated
C. albicans isolates in 7 biotypes, each occurring in a single
subject (Table 2).
Candida albicans was never isolated in samples from
V1 and V3, while it generally represented the sole or the
dominant species among cultivable fungi in samples from
the other six subjects. In subject V5, the C. albicans 8 D
recurred at all the time points as the most abundant among
cultivable fungi (72–100%). C. zeylanoides was found only in
V1, with one of the two biotypes present at all the time-
points as one of the most abundant fungal isolates (35–61%).
The NAC isolates belonging to the species C. parapsilosis,
C. pararugosa, C. guillermondi, and C. lusitaniae never occurred
more than once in the same individual and accounted for 4–23%
of the isolates.
Geotrichum candidum was isolated only from V1 and V2.
In the latter subject, it presented five biotypes, one of which
recurring across different time points and being always dominant
among the isolates. R. mucilaginosa was isolated from five
subjects. The species was particularly abundant in some samples
(up to 47% of the isolates inV1-II). S. cerevisiae, Debaryomyces
hansenii, and Aspergillus candidus were found only once in one
or in a few subjects, but were generally abundant. D. hansenii was
the dominant species in V3-III (58%).
Biofilm Formation
The ability of the fungal isolates to form biofilm in vitro was
investigated (Figure 3A; Supplementary Table S1). All but one
of C. albicans isolates produced large amounts of biofilm after
48 h of incubation, yielding OD540 values higher than 1.5.
Conversely, both the NAC and NCF did not form biofilm. On
average, the OD540 was 2.39 ± 0.79 for C. albicans, 0.21 ± 0.13
for NAC, and 0.20 ± 0.14 for NCF. The ability of C. albicans
to produce biofilms was significantly greater (P < 0.05) than
that of NAC and NCF.
Adherence of Fungal Isolates to Human
Epithelial Cells Caco-2
An in vitro adhesion assay employing the human colorectal
carcinoma cell line Caco-2 was used to evaluate the ability
of the yeast isolates to adhere to intestinal epithelial cells
(Figure 3B, Supplementary Table S1). The C. albicans isolates
adhered more efficiently (P < 0.05) than NAC and NCF ones
(13.4 ± 3.8, 8.1 ± 3.0, and 7.4 ± 3.9%, respectively). The
percentage of adherence to Caco-2 cells was >11% for most
C. albicans. Only two C. albicans isolates (i.e., 07-02 and 08-
06) showed a quite low adherence capability. Conversely, the
majority of NAC adhered less than 9%, with only few strains
(C. parapsilosis 01-18, C. pararugosa 04-14, C. zeylanoides 01-03)
showing values comparable to those of C. albicans. This feature
was not species-specific, since other strains did not present
similar behavior.
Human β-Defensin 2 Production by
Caco-2 Cells Exposed to Fungal Isolates
The secretion of HBD-2 by Caco-2 epithelial cells was
analyzed after exposure to the fungal isolates (Figure 3C and
Supplementary Table S1). The cells challenged with C. albicans
produced higher amounts of HBD-2 than those treated with NAC
or NCF (P < 0.05). The response of Caco-2 cells to the diverse
isolates of C. albicans was quite different, with HBD-2 levels
ranging between 2.6 and 592.7 pg/mL. In contrast, most of the
NAC did not induce any HBD-2 production, with the exception
of five strains that prompted the release of 2.0–47.5 pg/mL HBD-
2. NCF caused a variable accumulation of HBD-2 (51.7 ± 40.6
pg/mL). Issatchenkia terricola and Pichia manshurica did not
induce any HBD-2 production. G. candidum caused the highest
HBD-2 release within NCF isolates, ranging between 71.4 and
TABLE 1 | Counts of cultivable fungi in the feces of eight healthy volunteers, collected at 0 (I), 3 (II), and 12 months (III).
Subject Cultivable fungi (cfu/g)
I II III
V1 (8.1 ± 1.8) × 102∗ (9.9 ± 1.2) × 102∗ (3.6 ± 0.2) × 103
V2 (2.9 ± 0.7) × 103 (6.3 ± 0.8) × 102 (4.5 ± 0.2) × 105
V3 <102 (2.6 ± 0.6) × 104∗ (2.1 ± 0.3) × 104∗
V4 (2.2 ± 0.9) × 103∗ (3.6 ± 0.6) × 102 (1.4 ± 0.1) × 103∗
V5 (4.5 ± 1.7) × 102 (3.3 ± 1.0) × 103 (1.8 ± 0.2) × 103
V6 (2.7 ± 0.6) × 102 <102 <102
V7 <102 <102 (5.9 ± 0.6) × 102
V8 (1.4 ± 0.1) × 104 (4.7 ± 0.7) × 102 (6.2 ± 0.3) × 104
Values are means ± SD, n = 3. Within each row, for samples presenting detectable loads, ∗ indicate means that did not significantly differ (P > 0.05).
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TABLE 2 | RAPD-PCR, SSCP, and MLP analysis of fungal isolates.
Subject I II III
Isolates Biotype∗ r.a. (%) Isolates Biotype∗ r.a. (%) Isolates Biotype∗ r.a. (%)
V1 Candida zeylanoides
01-03
2 61 Rhodotorula
mucilaginosa 01-08
13 38 Candida zeylanoides
01-15
2 47
Candida zeylanoides
01-04
3 23 Candida zeylanoides
01-11
2 35 Candida lusitaniae
01-17
19 20
Candida pararugosa
01-07
1 8 Rhodotorula
mucilaginosa 01-09
10 9 Rhodotorula
mucilaginosa 01-20
10 14
Exsofiala dermatitidis
01-06
4 8 Issatchenkia terricola
01-10
11 9 Candida parapsilosis
01-18
9 7
Penicillium crustosum
01-12
12 9 Geotrichum candidum
01-19
20 7
Pichia manshurica
01-14
21 5
V2 Geotrichum candidum
02-01
5 86 Geotrichum candidum
02-09
14 86 Geotrichum candidum
02-11
14 100
Geotrichum candidum
02-02
6 7 Candida albicans 02-10 8 A 14
Geotrichum candidum
02-03
7 7
V3 – Saccharomyces
cerevisiae 03-01
15 100 Debaryomyces hansenii
03-10
23 58
Candida guilliermondii
03-03
22 16
Candida parapsilosis
03-04
9 12
Talaromyces
purpureogenus 03-02
25 7
Penicillium diversum
03-09
24 5
Rhodotorula
mucilaginosa 03-05
10 2
V4 Candida albicans 04-02 8 B 88 Aspergillus candidus
04-08
16 50 Candida albicans 04-10 8 C 73
Rhodotorula
mucilaginosa 04-01
10 8 Aspergillus candidus
04-21
17 25 Candida pararugosa
04-14
1 23
Candida parapsilosis
04-04
9 4 Aspergillus candidus
04-22
18 25 Saccharomyces
cerevisiae 04-11
26 4
V5 Candida albicans 05-01 8 D 100 Candida albicans 05-05 8 D 84 Candida albicans 05-09 8 D 72
Rhodotorula
mucilaginosa 05-06
10 16 Rhodotorula
mucilaginosa 05-07
10 28
V6 Candida albicans 06-01 8 E 100 – –
V7 – – Candida albicans 07-02 8 F 100
V8 Candida albicans 08-06 8 G 98 Candida albicans 08-08 8 G 98 Saccharomyces
cerevisiae 08-11
27 100
Issatchenkia terricola
08-03
11 2 Rhodotorula
mucilaginosa 08-07
10 2
Taxonomic characterization through ITS sequencing and relative abundance are reported for each cluster identified in the eight volunteers at 0 (I), 3 (II), and 12 months
(III). – Indicates that no fungal colonies were isolated. ∗Numbers indicate RAPD-PCR profiles; letters represent SSCP and MLP fingerprinting profiles of Candida albicans
isolates. r.a., relative abundance expressed as %.
110.9 pg/mL, followed by R. mucilaginosa (36.1–78.6 pg/mL), and
by S. cerevisiae (8.5–18.5 pg/mL).
Yeast Colonization of the Murine GIT
Nine yeast isolates, i.e., 3 C. albicans (C. albicans 02-10,
C. albicans 04-10, and C. albicans 08-06), 3 NAC (C. parapsilosis
01-18, C. pararugosa 04-14, and C. zeylanoides 01-03), and 3
NCF (G. candidum 02-01, R. mucilaginosa 04-01, and S. cerevisiae
03-01), were tested for the ability to colonize the GIT of mice.
Yeasts were daily given to mice for 14 days and the persistence
in feces was evaluated at the end of the treatment (0), then
after 2, 4, and 8 weeks of washout (Figure 4). All the strains
were recovered at the end of the supplementation period. The
most abundant were C. albicans 02-10, C. parapsilosis 01-18,
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FIGURE 3 | Health relevant properties of the fungi isolated from fecal
specimens of healthy donors: biofilm production (A), adhesion to epithelial
Caco-2 cells (B), and induction of HBD-2 production in CaCo-2 cells (C).
Boxes indicate the median and 25th and 75th percentiles; whiskers indicate
10th and 90th percentiles; ∗ indicate groups with significantly different means
(P < 0.05).
C. pararugosa 04-14, and R. mucilaginosa 04-01, all presenting
a mean concentration >3.0 Log10 cfu/g. C. albicans 04-10 and
C. zeylanoides 01-03 were the less abundant, with a mean
FIGURE 4 | Concentration of the strains of Candida albicans (cyan), NAC
(orange), and NCF (green) in the feces of mice groups during the wash period
that followed the treatment with C. albicans 02-10, C. albicans 08-06,
C. albicans 04-10, C. parapsilosis 01-18, C. pararugosa 04-14,
C. zeylanoides 01-03, G. candidum 02-01 (G), S. cerevisiae 03-01 (H), and
R. mucilaginosa 04-01 (I). Values are means (n = 10), the error bars
representing the SD. For each strain, ∗ indicate statistically significant
difference compared to 0 weeks values (Wilcoxon signed-rank test, P < 0.05).
concentration <1 Log10 cfu/g. C. albicans 04-10, the NAC, and
the other yeasts dropped below the limit of detection after
2 or 4 weeks of washout. On the other hand, C. albicans
02-10 and C. albicans 08-06 were found for up to 8 weeks
after the end of treatment. The former strain remained in
the range of 1–3 Log10 cfu/g throughout the whole washout
period, whereas the latter drastically decreased in the first
2 weeks, remaining present, although sporadically, in the feces
of mice after 8 weeks.
DISCUSSION
This study investigated the fecal mycobiome in healthy adults
over a time span of 12 months, using ITS1 deep sequencing
combined with a culture-based method. The ITS profiling
provided a comprehensive description of the fungi harbored in
the intestine, whereas isolation of viable fungi allowed the study
of the properties involved in gut colonization. Compared to the
bacterial microbiome, the biodiversity of fungal communities was
lower and characterized by greater unevenness, in agreement
with previous studies (Qin et al., 2010; Suhr and Hallen-Adams,
2015; Nash et al., 2017). Most samples were dominated by one
or two fungal genera. The unevenness in fungal composition
resulted in great distances both among subjects and over the
time within the same subject. This was consistent with the
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occurrence of fungal cells transiting through the GIT without
being stable colonizers, or with the possibility of a high variability
in the individual mycobiome. On the contrary, the bacterial
microbiome yielded subject-based clusters coherent with a more
stable resident community inhabiting the intestine of each donor.
Previous studies and the data herein presented consistently
indicated Aspergillus, Candida, Debaryomyces, Malassezia,
Penicillium, Pichia, and Saccharomyces as the most recurrent
and/or dominant fungal genera. The major discrepancies with
literature were associated with the detection of Mucor and to
the absence or scarcity of some genera such as Cladosporium,
Clavispora, Cyberlindnera, and Galactomyces (Hoffmann et al.,
2013; Strati et al., 2016; Nash et al., 2017; Auchtung et al.,
2018; Borges et al., 2018). Geographic distribution of the
volunteers and diet habits probably accounted for the differences
observed, since the present study and Strati’s investigation,
both enrolling volunteers in Italy, come to similar conclusions.
Many species of Aspergillus and Penicillium detected in this
trial, each occurring sporadically and/or negligibly in terms of
abundance, are regarded as health concerns, being potential
sources of mycotoxins or opportunistic infections targeting
mucosal tissues (Hedayati et al., 2007; Perrone and Gallo, 2017;
Perrone and Susca, 2017). This supported the hypothesis of their
transient presence in the gut as a result of the consumption of
exogenous sources, such as contaminated food and beverages.
In the GIT, fungal population can be made by true inhabitants
or by microbes occasionally ingested with fermented or spoiled
foods, likewise lactic acid bacteria abundantly occurring in
food (Rossi et al., 2016). Despite Aspergillus and Penicillium
were found in nearly all the samples, isolates ascribable to these
genera were obtained only in a minority of cases. A similar
observation was reported also by Strati et al. (2016) and suggests
that fecal Aspergillus and Penicillium may be allochthons that
do not survive the gastrointestinal transit. Likewise, other
frequent and abundant taxa detected in the metagenomic survey
(e.g., Mucor, Malassezia) were not identified by culture-based
analysis, raising the question of whether they were actually viable
inhabitants of the GIT.
The genus Candida was identified by metagenomics survey
in most samples, occasionally occurring at remarkably high
amounts. Unlike previous studies, C. albicans was not detected
(Hoffmann et al., 2013; Seed, 2014; Suhr and Hallen-Adams,
2015; Strati et al., 2016; Suhr et al., 2016; Nash et al., 2017;
Auchtung et al., 2018; Borges et al., 2018). Most of the Candida
genus-related sequences received the “Candida unidentified”
taxonomy using the last available version of the UNITE
database (release 2017-12-01), but were given the designation
“Candida albicans” if a previous version was utilized (release
2015-08-01) (Supplementary Figure S3). This underlines
that the reliability of reference databases is pivotal for a
consistent taxonomic attribution and for the comparison
with other metagenomic studies and culture dependent
approaches. As a matter of fact, isolates of C. albicans were
frequently obtained and dominated the cultivable mycobiota
of different samples. The molecular fingerprinting of the
isolates lead to the identification of strains that longitudinally
persisted within the same subject, likely as commensals
inhabiting the intestine or systematically reaching it from
the oral cavity.
Only few NAC species (C. ethanolica, C. inconspicua,
C. parapsilosis, C. tropicalis, and C. zeylanoides) were detected
by metagenome analysis. Evidence of a possible stable
colonization was provided for C. zeylanoides by culture-
dependent experiments, with a biotype isolated in the feces of
a subject over a time span of one year. Based on the present
metagenomics analysis, S. cerevisiae resulted as one of the most
frequent and abundant species. Albeit cultivation of S. cerevisiae
is generally not an issue, isolates were obtained only from two
samples. This result was in agreement with a previous study,
where the isolation succeeded only in a minority of samples
(4/111) (Strati et al., 2016). Therefore, conclusive evidence was
not obtained establishing whether S. cerevisiae is an occasional
or a permanent colonizer of the human GIT. A recent study
conducted a phylogenetic analysis on 12 microsatellite loci and
1715 combined CDSs from whole-genome sequencing on a
set of S. cerevisiae strains isolated from the gut of normal and
inflammatory bowel disease patients (Ramazzotti et al., 2019).
The analysis revealed evidence of clonal colonization within
the host’s gut. The phenotypic analysis of the isolates combined
with immunological profiling indicated that both genetic and
environmental factors involved in cell wall remodeling and
sporulation are the main drivers of adaptation in S. cerevisiae
populations in the human gut. The most likely hypothesis is that
a combination of specific genetic features in the microbe and
in the host allow colonization from microorganisms normally
present solely as passengers, often when alterations in the
gastrointestinal barrier occur (Sokol et al., 2017).
Fingerprinting of the NCF isolates pointed out that also
the G. candidum and R. mucilaginosa may stably inhabit
the GIT, even if genera Geotrichum and Rhodotorula were
not detected by metagenome survey. However, the family of
Dipodascaceae which includes the genus Geotrichum was found
to be abundant in the corresponding samples. Interestingly,
metagenomic revealed that also the ecologically understudied
D. udenii is a putative permanent colonizer that, when detected,
is present in all the samples of the same subject.
Functional investigation focused on comparison of
C. albicans, NAC and NCF isolates. C. albicans adhered to
human epithelial cells more efficiently than NAC and NCF
and produced greater amounts of biofilm in vitro. In contrast,
NAC and NCF were not biofilm producers. This evidence is
in agreement with previous studies biofilm formation by of
C. albicans and/or other fungi, such as S. cerevisiae (Chandra
et al., 2001). Although the fungal population investigated in this
study has been isolated from the stool of healthy volunteers,
the ability to adhere and to form biofilm appears to be a trait
peculiar of the opportunistic fungus C. albicans, the behavior
of which supports the potential virulence and the impact on
clinical infections.
Increasing evidence indicates that fungi may stimulate host
intestinal immune system, beneficially affecting host homeostasis
(Yan et al., 2013). The C. albicans isolates also induced the highest
release of HBD-2 by human epithelial cells, further differing from
NAC and NCF. On these bases, our results suggest that the release
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of HBD-2 by C. albicans may have an important role in regulating
the size and the activity of the fungal population harbored in
the gut of healthy individuals. The intestinal epithelial cells
play a crucial role in local antimicrobial defense, since they not
only represent a physiologic barrier for pathogens, but they also
function as a part of innate immune system via production of
antimicrobial peptides and cytokines, such as HBD-2, endowed
with a wide spectrum of antibacterial and antifungal activity
(Ganz, 2003; Selsted and Ouellette, 2005).
Three representative fungal isolates from each group have
been administered to mice to evaluate the ability to colonize
the intestine. Only two out of three C. albicans isolates were
recovered from the stools of animals, 8 weeks after the end
of the treatment. In contrast, the other tested fungi including
NAC and NCF were not isolated yet after 2 weeks of wash-
out. These results provide expand initial evidence on the
allochthonous nature of most fungi in the gut, confirming that
stability of mycobiota in the intestine over the time is quite low
(Erturk-Hasdemir and Kasper, 2013).
CONCLUSION
NGS approach combined with a culture-based methods revealed
that most of the fungi transit through the GIT without being
stable colonizers. The panel of fungi detected by metagenomic
surveys is dominated by environmental or food-borne taxa
that are rather washed out by the gastrointestinal transit, while
only a minority of viable fungi behave as stable colonizers,
with certain biotypes being longitudinally persistent within a
subject. Notoriously, C. albicans exhibits features involved in
stable colonization (e.g., transition to hyphal form, biofilm
formation, adhesion to intestinal epithelial cells). Accordingly,
it is the sole species that successfully colonized the murine
intestine. It remains to be established if other species, herein
identified as putative colonizers, such as D. udenii, C. zeylanoides,
G. candidum, S. cerevisiae, and R. mucilaginosa, are true
inhabitants of the intestine or are delocalized from other body
districts. A combination of specific features in the microbe and
in the host seems the driver of colonization of microorganisms
normally present solely as passengers. As whole, the fungal
microbiome is much more variable at the individual level than
the bacterial one.
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